Physician
Nazim, Lubna
Nazim, Lubna was paid $1K by Medicaid between Jan 2018 and Nov 2024, across 43 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 66% of everything it billed.
33Billing provider infoNAZIM, LUBNA
LOS ANGELES, CA 90003
LOS ANGELES, CA 90003
33aNPI1952443509assigned 02/12/2007
33bProvider typeInternal Medicine Physician
28Total paid$1K
24GClaims18,769
24DCodes billed43
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#1,991 of 2,679
Median peer was paid$13K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 738 | $501.76 | |
| 2019 | 936 | $767.92 | |
| 2020 | 3,042 | $0.00 | |
| 2021 | 3,344 | $0.00 | |
| 2022 | 3,152 | $0.00 | |
| 2023 | 3,165 | $0.00 | |
| 2024incomplete | 4,392 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 66% | 1,132 | 922 | $833.34 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 293 | 270 | $327.26 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.6% | 1,793 | 1,581 | $109.08 |
| 80061 | Lipid panel | 0% | 1,482 | 1,479 | $0.00 |
| 82540 | 0% | 350 | 345 | $0.00 | |
| 86703 | 0% | 443 | 441 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 16 | 12 | $0.00 |
| 3077F | 0% | 121 | 112 | $0.00 | |
| 99442 | 0% | 293 | 281 | $0.00 | |
| 3078F | 0% | 442 | 396 | $0.00 | |
| 90658 | 0% | 13 | 13 | $0.00 | |
| 84450 | 0% | 12 | 12 | $0.00 |
31 more codes
| 82274 | 0% | 142 | $0.00 | |
| 3051F | 0% | 13 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 37 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 14 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 18 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 1,461 | $0.00 |
| 1220F | 0% | 316 | $0.00 | |
| 3044F | 0% | 173 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 872 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 356 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 188 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 1,998 | $0.00 |
| 85027 | 0% | 744 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 448 | $0.00 |
| 82043 | 0% | 350 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,632 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 430 | $0.00 |
| 3079F | 0% | 52 | $0.00 | |
| 4450F | 0% | 258 | $0.00 | |
| 86593 | 0% | 136 | $0.00 | |
| 81001 | 0% | 40 | $0.00 | |
| 90686 | 0% | 41 | $0.00 | |
| 3074F | 0% | 360 | $0.00 | |
| 99441 | 0% | 26 | $0.00 | |
| 3075F | 0% | 67 | $0.00 | |
| 1111F | 0% | 94 | $0.00 | |
| 94760 | 0% | 30 | $0.00 | |
| 86592 | 0% | 12 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 37 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 18 | $0.00 |
| 90656 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.